Junebug, if we are working with Merck and they are selling our product for us, then we likely have FDA approval. If we have FDA approval, then we could have government contracts, and that is likely if insurance is indeed covering the product. Also, that would likely be the way opioid addiction would be treated for free (a government program). So in my opinion, the NASDAQ would be the lowest board we would be listed on. Something to think about, and right now we are only talking about a single product, but I suspect there will be many, many products.